Vitamin D is also known as the sunshine vitamin, as the body produces it when we are exposed to the sun. However, a lack of this vitamin can result in symptoms such as headaches.
Many people in the northern hemisphere are unaware that they can actually be experiencing a vitamin D deficiency, especially as the cold winter months have very little sunshine. Express reports that vitamin D deficiency can lead to symptoms like severe chronic headaches.
A study regarding this subject found that men who lacked vitamin D were more than likely to experience chronic headaches at least once a week. It also bears noting that men from the northern hemisphere reported getting more headaches from the months of October to May, at the time when levels of vitamin D are much lower in this part of the world. While it is unclear why a lack of vitamin D may cause headaches, researchers theorize that the vitamin may also have anti-inflammatory properties along with nerve-related pain.
Experts recommend that children one-year-old and above, as well as adults, need 10 micrograms of vitamin D a day. Pregnant and or breastfeeding women need this amount as well, including those who are at risk of a vitamin D deficiency. People who are often indoors, work in an institution, and people who cover up most of their skin when outside are at risk of a vitamin D deficiency.
Fortunately, being able to get all the vitamin D recommended is easy. Along with exposure to sunlight, there are foods rich in vitamin D and vitamin D supplements. Fatty fish, egg yolks, cheese, and other fortified foods are good sources of vitamin D.
While restoring vitamin D levels is good, too much of it can lead to symptoms that can be problematic. Another report reveals that too much vitamin D supplements can lead to what experts call vitamin D toxicity and some of the symptoms that can occur when this happens are frequent urination.
Too much vitamin D can lead to the blood retaining a little too much calcium which results in a condition called hypercalcemia. Among the symptoms of hypercalcemia, include frequent urinating, vomiting, nausea, loss of appetite, disorientation, confusion, and double thinking.


Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



